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Based on immunologic and epidemiologic data, it is 
plausible that skin cancer in renal transplant recipi-
ents is associated with human papillomaviruses 
(HPV). At present, conflicting evidence exists con-
cerning the presence of HPV DNA in these cancers. 
We recently described a nested polymerase chain 
reaction method that enables the detection of all 
previously isolated epidermodysplasia verruciformis 
(EV)-associated HPVs. We now describe the detec-
tion of EV-associated HPV DNA in 49 (80%) of 61 
biopsies from squamous cell carcinomas, in four 
(50%) of eight basal cell carcinomas, in 14 (93%) of 15 
actinic keratoses, in two (40%) of five cases of Bo-
wen's disease, and in four (57%) of seven keratoacan-
thomas . 
R enal t. ransplant recipients are at an incre~sed ~sk f~r both warts and skin cancer [1-3) . Ep•denuolog1c data suggest an important role for human papillo-mavirus (HPV) infection in the development of skin cancer in immunosuppressed patients . T he 
number of keratotic skin lesions, consisting of wa.rts, solar kerato-
ses, and hyperkeratotic papillomas, is highly associated with both 
squamous cell carcinomas and basal cell carcinomas in renal 
transplant recipients [3,4]. !J1 addition, patients without an apparent 
class switch from IgM to lgG to one of the capsid proteins (L1) of 
HPV type 8 appeared to have an increased d sk of skin cancer as 
compared to p;1tients with a good humoral response to tlus antigen 
[5]. HPV 8 belongs to the subgroup of HPV types that is predom-
inantly associated with the rare hereditary disease epidem10dyspla-
sia verruciformis (EV), a disease characterized by extensive HPV-
associated wart-like and scaly lesions and a !ugh ri sk for the 
development of squamous cell carcinomas [6] . ln the above-
mentioned serologic tests cross-reactivity was noted between the 
HPV 8 L1 protein and L1 proteins of other EV-associated HPVs, 
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HPV DNA typing revealed that all detected HPV 
types belonged to the EV -associated HPV types. A 
wide spectrum of EV-associated HPVs was found, 
including six putative new HPV types. In a high 
percentage of the lesions more than one HPV type 
was detected. We often found the same HPV types in 
different skin biop~ies from both malignant and pre-
malignant lesions from the same patient. 
The high frequency of detection of EV -associated 
HPV types in biopsies from malignant and premalig-
nant lesions is in agreement with the hypothesis that 
EV-associated HPVs are involved in the pathogenesis 
of skin cancer in renal transplant recipients. Key 
IVOt'ds: polymerase chain reactiotl!skin Callcer. 1 ltlvest Der-
matol 105:367-371, 1995 
but not with non-EV-associated HPVs like HPV 1, 2, 6, 16, or 18 
[5] . T herefore, the serologic findings in renal transplant recipients 
suggest the presence of a virus belonging to the EV -associated 
subgroup rather than of HPV 8 alone. 
T he data concerning the detection of HPV DNA in skin lesions 
of renal transplant recipients are conflicting. Some authors have 
found a high prevalence ofHPV DNA in skin carcinomas of these 
patients. Using dot blot hybridization, B arr et a/ [7] found DNA of 
the EV -associated HPV types 5 and 8 in 60% of 25 squamous cell 
carcinomas. T he group from Lyon [8] fow1d HPVs 1, 2, 16, and 18 
in 47% of 30 squamous cell carcinomas using iu situ hybridization , 
and the sam e group [9] reported mucosal HPV 6 and 11 in 71 % of 
24 squamo us cell carcinomas using polymerase chain reaction 
(PCR) and additiona.lly i11 sit11 hybridization and Southern blot 
hybridization . Recently Shamanin et a/ [10] reported the detection 
of a series of different HPV types (e .g., a novel HPV 29 -related 
typ e) in betugn and malignant skin lesions of renal transplant 
patients using a PCR with degenerate primers. Other groups found 
no HPV at all [11,1 2]. The explanation for tlus phenomenon of 
conflicting results is probably largely attributable to differences in 
the techniques used . For a m ea.tung ful assessment of the presence of 
HPV in these lesions, it is necessary to use a technique that is not 
only sensitive (for example, the PCR) , but also able to detect a 
wide range of HPV types. In addition, the teclm.ique should be 
suitable for reliable typing of the HPV DNA. 
Previously, we were able to detect DNA ofEV-associated HPV 
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in fiv e (21 %) of 24 squamous cell carcinomas of renal transplant 
recipients with four different PCR m ethods each using a different 
consen su s prin~er pair (termed A , B, C, and D) located in the El 
open reading frame [13] . For the current study, a nested PCR 
m ediated by four consensus primers was used with annealing sites in 
the Ll open reading frame of the viral genome. This PCR enabled 
the detection of all previously isolated EV-associated HPVs [14]. 
This study, utilizing this n este d PCR, reports the detection of 
DNA of EV- associated HPV types in a high percentage of squa-
mous cell carcinomas, basa l cell carcinomas, and premalignant 
lesions from renal transplant recipients. 
MATER.lALS AND METHODS 
Biopsy Specimens Ninety-six biopsy specimens were obtained from 
premalignant and malignant skin lesions from 44 renal transplant recipients. 
T he specimens were snap-frozen and stored at - 70°C. From each lesion a 
duplicate punch biopsy was taken for histologic examination. Control 
specimens consisted of23 snap-frozen biopsies of non-tumorous skin lesions 
of 20 non-immunocompromised patients (vasculitis, chronic discoid lupus 
erythematosus, bullous pemphigoid , eczema, polymorphic light eruption, 
lichen planus, and non-specified dcm1atitis) and three biopsies of clinically 
normal skin from the buttocks of three renal transplant recipients. 
DNA Preparation The snap-frozen skin biopsies were thoroughly 
minced, and cellular DNA was isolated by overnight incubation at 56°C in 
a 50 mM Tris-HCl (pH 8.5), 50 mM ethylenediaminetetraacetic acid 
solution containing 100 !J.g/ml pcoteinase K. Proteinase K was heat 
inactivated and DNA was subsequently extracted using the guanidinium 
isotluocyanate (GTC)-diatom method according to Doom and co-workers 
(15]. 
PCR Primers We used a nested PCR. method as described previously 
(14] consisting of two degenerate primers, termed CP65 and CP70, located 
in tl1e L1 open reading frame . The C P65/CP70 primer set (F) amplifies a 
452- 467-bp product depending on the target HPV type. For the second 
step (nested) PCR a primer set (G) consisting of the degenerate primers 
CP66 and C P69 was used, amplifying a 374-389-bp product. [n a separate 
reaction, a /3-globin PCR. was carried out using the primer pair PC03 
(glo-1) and R.S42 (1 6]. 
HPV Detection PCR. amplification was performed exactly as previously 
described (14] using a 50-!J.l reaction mixture containing 50 mM KCl, 10 
mM Tris-HCl (pH 8.8) , 3.6 mM MgC12 , 0.1 mg/ml bovine serum albunlin, 
0.2 mM of each deoxynucleotide triphosphate, 1 U of Taq DNA poly-
merase, and 300 ng of both primers. In the first-step PCR, 5 !J.I ofDNA (0 .5 
to 2% of to tal extractable DNA of the lesion) was used as an input. The first 
PCR amplification consisted of fi ve cycles with a 1-nlin denaturation step at 
95°C, a 1.5-nun annealing step at 50°C, and a 2-nlin extension step at 72°C, 
followed by 35 cycles with a higher annealing temperature (l min at 95°C, 
1 min at 55°C, and 2 nlin at 72°C). In the second step (nested) PCR, 3 !J.l 
of the first step PCR was used as an input. In tlus PCR 30 cycles of 
amplification (1 min at 95°C, 1 nun at 55°C, and 2 nun at 72°C) were 
performed. For every two PCR reactions a negative control (water only) 
was included. These controls were processed the same way as the tissue 
specinlens tllCoughou t the DNA preparation and the first- and second-step 
PCR and were never found positive for HPV. 
With tlus tecluuque all known EV-associated HPV genotypes couid be 
amplified. The sensitivity of the PCR., as tested for four different EV-
associated HPV types (HPV 8, 15, 20 and 23), ranged from l to 10 fg [14]. 
Other cutaneous I-IPV types, witl1 the exception of HPV 1, could not be 
amplified or were only amplified by primer set F (HPV 2, 26, and 27). 
Genital HPV types 6, 11, 13, 16, 18, 31 , and 33 could also be detected. 
HPV DNA typing was performed by direct sequence analysis of the PCR 
amplimers as described earlier [14] . 
RESULTS 
Ninety-six biopsies were taken from the following skin lesions from 
44 re nal transpla11t recipients: 61 squamous cell carcinomas, eight 
basal cell carcinomas, five cases of Bowen's disease, 15 actinic 
keratoses, and seven keratoacanthomas. The lesions were examined 
by a nested PCR method using first the consensus prin1er pair F 
followed by reamplification of the PCR product with the nested 
consensus primer pair G. The amplified HPV DNA fragments were 
typed by sequence analysis as described in Materia ls a.td Methods . 
The prevalence of HPV DNA is presented in Table I. 
In 23 of the 55 HPV-positive skin lesions in which HPV typing 
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Table I. Prevalence of HPV DNA as Detected by Two 
Different PCR Methods in 96 Skin Lesions from 44 Renal 
Transplant Recipients 
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" The HPV rypes were determined after direct sequencing of the PCR amplimer and 
by comparing tills sequence with the sequences of the amplified PC R products of all 
known EV-associated 1-IPV types. Some HPV types were fo und more then once, as 
indicated in superscript between parentheses . HPV X l through X6 indicate uovel, 
EV-associatcd HPV types (sec (14)) . M indicates the presence of more than one HPV 
type in one lesion, fro m which at least one type could be sequenced, as indicated 
between brackets. mix indicates the presence of more than one HPV type in one lesio n, 
in which HPV typing was not successfully done. ND, not d e te rmined. 
was successfully performed by direct sequence analysis of the 
ampli.fied fragment, more than one HPV type was present based on 
the sequence pattern. In most of these cases only the predominant 
HPV type could be determined. In only some of these cases we 
wer~able to molecularly clone and sequence the PCR amplimers , 
so that typing of the individual types in these HPV mixtures could 
be accomplished (see Table 1) . All samples that were sequenced 
contained DNA of HPV types that belong to the group of 
EV-associated HPV types or HPV types resembling these types . 
The following known HPV types w e re found: HPV 15, 19, 20, 21, 
23, 24, 25, and 38. We often found genetic heterogeneity (intra-
typical variability) within the amplified sequences of these HPV 
types, especially among different patients. This intratypical variabil-
ity averaged between 5 and 10% , but most of the nucleotide 
substitutions proved to be silent in the coding sequence . Phyloge-
netic analysis using the sequences of the PCR amplimers showed 
that the sequences of six HPV types (termed X1, X2, X3, X4, XS, 
and X6) were clearly distinct from the other known EV HPVs. The 
intertypical variability at nucleotide leve l ranged from 22 to 40%, 
indicating that Xl to X6 are putative novel HPV types belonging to 
the group of EV -associated viruses [14]. 
All control specimens, as described in Materials aud Methods, 
re mained negative, excluding contamination with HPV DNA and 
false positivity of the PCR. The DNA extracted from these control 
specimens was adequate for PCR analysis, because successful 
amplification of a J3-globin PCR fragment was carri.ed out in all 
cases. 
In a previous study [13) we described the presence of EV-
associated HPV types in five (21 %) of24 squamous cell carcinomas , 
in one of three cases of Bowen's disease, in two of seven actinic 
keratoses, and in one of five keratoacanthomas using four (single-
step) PCR methods, each with a different consensus primer set (A, 
B , C, and D). For our present study we used the same biopsies as 
well as additional biopsy specimens. Comparing the results from 
our previous study with our nested PCR method (utilizing primer 
pairs F and G), it is clear that a much higher percentage of the 
samples turned out to be HPV positive (Table!). In addition, in five 
cases other HPV types were detected with our previous PCR 
method [13) as compared to the nested PCR. HPV 10 and an HPV 
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Table II. HPV Types Detected in Different Skin Lesions from a Selection of Renal Transplant Recipients with Three 
or More Lesions Studied 
Patient Number Sex/Age Lcsiont' Loca lization Nested PCR HPV Types'' 
F/41 sec Hand + 24 
BCC Upper ann + 24 
Bowen's disease Back 
2 M/52 sec Lower arn1 + XI 
sec Hand + Xl 
sec Back + Xl 
BCC Face + XI 
3 M/47 sec Hand + 25 
sec Hand + 20 
sec Elbow + 25 
4 M/46 sec Face/skull + Mix 
sec Facc/skttll + 23 
sec Wrist 
5 F/65 sec Finger + Mix 
sec Lower ann + X4 
sec Lower leg + 38 
sec Lower leg + ND 
Bowen' s disease Upper ann + X4 
6 M/63 sec Hand + ND 
sec Hand + Mix 
sec Face + M(15 + XJ) 
sec Hand + 15 
Actinic k eratosis Face + Mix 
Actinic keratosis Face + Mix 
Kcratoacanthon1a Face + M(l5 + XJ) 
Keratoacanthon1a Face + M(15 +XI) 
7 M/41 sec Lower leg 
sec Lower l<!g + ND 
sec Hand + Mix 
Actinic keratosis Upper leg + 15 
8 M/68 sec Lower leg + M(15 + 20) 
sec Face + M(l5 + 20) 
sec Hand + Mix 
Bowen's disease Face + M(15 + 20) 
~ SCC, squnmous cell cn rdnoma; BCC, basal cc iJ c;1.rciooma. 
h HPV Xt and X4 indicate nove l 1-IPV types. M indicates the presence o f more thnu one HPV type in o ne lesion. from which at least one type could be sequenced, as indicated 
becween brackets. M.ix indicates the presence of more than one HPV type in one lesion, in which HPV typing was not successfully done. ND. not dctcm1ined. 
10 -related HPV type were found in o ne actinic keratosis and in one 
keratoacanthoma w ith primer set A, whereas with the nested PCR 
a mixture of yet un typed HPVs and no HPV was detected 
respectively. In one case of Bowen 's disease HPV 36 was found 
with o ur previous PCR method, whereas the nested PCR revealed 
the presence of HPV 1.5 and 20. In two squamous cell carcinomas 
HPV 14 and an HPV 1.4-rela ted HPV type were found with our 
previous PCR m etho d , and a yet un typed mixture of HPV types 
was found with the nested PCR. T hese apparent discrepant results 
are probably due to the relatively frequent occurrence of mixed 
HPV infections in the skin lesions in combination with the different 
spectrum of HPV types detected by the different PCR methods. 
In Table II the PCR results of eight patients of w hom three or 
more skin lesions were studied are presented. The same HPV types 
were often detected in different biopsies from skin les ions from the 
same patient. It is very unlikely that this is due to carryover ofHPV 
DNA from one specimen to an other, because most skin biopsies 
from di..tferent lesions from the same patient were obtained and 
processed on clifferent dates . Moreover, negative contro ls processed 
in between the patient samples remained negative. Of course, we 
cannot exclude the poss ibility that the patients themselves arc the 
source of contamination, spreading HPV fi~om one les ion to 
another. 
The resul ts of nested PCR amplification ofHPV DNA present in 
biopsies from skin lesions from four renal transplant recipients are 
presented in F ig 1. 
D ISCUSSION 
With our recently developed nested PCR method , we fow1d HPV 
DNA in a high percentage of m alignant and premalignant skin 
lesions from ren al transplant rec1p1ents. In our single- step PCRs 
(primer sets A, B, C, and D) [13], we detected HPV DNA in no 
more than 21% of the skin cancers. In contrast, using the more 
sensitive nested PCR approach, we detected HPV DNA i.n 80% of 
the same skin cancers ([14] and Table 1). The present data show 
that not only the malignant, but also a high percentage of otl1er 
1 2 3 4 5 6 7 8 9 M N P 
Figure 1. PCR products are shown after electrophoresis in an 
ethidium bromide-stained gel. Patient 1 in Table II, basal ce ll carci-
noma (BCC) (laue 1) and squamous cell carcinoma (SCC) (ln11e 2); patient 
2, sec (/aile J) . nee (laue 4). and sec (/nile 5); patient 3, three sees (lnues 
6 - 8); patient nor mentioned in Table II. actinic keratosis (/nut• 9) . A 
1 00-base pair marker (laue Nf), a negative control (water) (laue N), and a 
positive control (Hl'V 8) (P) arc included. 
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lesions (Bowen's disease, actinic keratoses and keratoacanthomas) 
of renal transplant recipients contain HPV DNA. 
We detected HPV types that until now were presumed to be 
largely restricted to skin lesions from patients sufferin g from EV. In 
addition, we detected six putative new HPV types that were found 
to be closely related to the already known EV -associated HPV 
genotypes. For the definitive recognition of these types as novel 
types the sequences of the E6, E7, and L 1 open reading frames of 
the cloned genomes must be compared with that of all other known 
HPV types. 
Direct sequencing of the PCR product allows reliable detenni-
nation of the HPV types (and sub types) present [14) . Interestingly, 
using tlus method, we did not detect HPV 5 and 8 in any of the 96 
tested skin lesion s. T hese HPV types are the main HPV types 
descr-ibed to be associated with skin cancers in EV patients [6). HPV 
5 was also the first HPV type detected in skin cancers of a renal 
transplant recipient by Southern blotting [17). Moreover, a high 
prevalence of HPV 5 and 8 in malignant and premalignant skin 
lesions from renal transplant recipients was observed by the group 
from Edinburgh [7) . For their study a dot-blot hybridization 
teclmique W'!S used, wluch is not only a less sensitive but also a less 
specific technique than the PCR. T herefore, it ca nnot be excl uded 
that their biopsies contained other EV-associated HPV types instead 
ofHPV 5 and 8 and that cross-hybridization caused a positive signal 
in their assay. ln a recent publication, using type-specific PCR 
primers, the same group did not find HPV 5 and 8 DNA in 31 
squamous cell carcinomas from renal transplant recipients. They 
detected (mostly non-typed) HPV DNA in 33% of the squamous 
cell carcinomas by Southern blot anal ysis and HPV 5 (but not HPV 
8) DNA in only tWo of 50 premalignant lesions and three of18 viral 
warts [18]. The group from Lyon did not detect HPV 5 DNA in a 
series of 27 malignant skin tumors from renal transplant recipients 
by in situ hybridization [19). T hey fow1d, however, that one of 
eight basal cell carcinomas and seven of 19 squamous cell carci-
nomas contained (unspecified) HPV DNA sequences other than 
HPV 5. Recently;_ Shamanin et a/ [1 0) reported the detection of 
HPV DNA in 11 of20 squamous cell carcinomas, three of five basal 
cell carcinomas, and two of eight cases of Bowen's disease using 
PCR with degenerate primers. Most of the HPV types present in 
the (pre)malignant skin lesions were uncbaracterized . ln one of 
these samples, EV-associated HPV type 20 was identified, and in 
three SCCs HPV type 29-related DNA was found. In the other 
(pre)ma.lignant skin lesioris other known HPV types , especially 
cutaneous types, were identified. In some of the benign skin lesions 
EV-associated HPV type 12, 15, 17, and 25 were detected. 
Comparing the results of the above-mentioned studies, one must 
realize th~i: the usc of different techniques could lead to the 
detection of different HPV types. O ur data indicate that often more 
than one HPV type is present in a single skin biopsy fro m a renal 
transplant recipient. As mentioned before, we fo und a mixture of 
HPV types in 23 of 55 (4 2%) HPV-positive skin les ions, in wluch 
HPV typing was succesfully don e by direct sequence analysis . It is 
therefore quite possible that different HPV types can be detected in 
the same lesion using PCR techniques wi~h different specificities. 
T lus probably also explains the discrepant results o btained for five 
cases with o ur previous PCR method and the nested PCR method 
described in tins manuscript. 
We did not find mucosal HPV types 6 and 11 in any of the 
malignant or premalignant skin lesions , although our nested PCR 
method was able to detect HPV types 6 and 11. Therefore we have 
no good explanation for the high prevalence of th ese HPV types in 
skin lesions as reported recently by the group from Lyon [9). HPV 
6 and 11 are usually only detected in benign genital lesions such as 
condylomas or benign laryngeal papillomas. T he skin lesions 
described by the group from Lyon were not checked for EV-
associated HPVs other than HPV 5, so it cannot be excluded that 
these HPV types were present in their biopsies. 
T he presence ofEV-associated J.lPV DNA in a high percentage 
of the biopsies from malignant and premalignant lesions in renal 
transplant recipients and the recurrent finding in several patients of 
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the same HPV types give support to the hypothesis that these HPV 
types play a ro le in the development of skin cancer in renal 
transplant recipients. On the other hand, the presence of multiple 
HPV types in o ne skin biopsy might argue in favor of the presence 
of HPVs as "passengers" in these lesions, in which case they may 
not be involved in the pathogenesis of these lesions. 
Some of the carcinomas re m ained negative with our nested PCR 
approach. It is possible that these carciJ1omas contain ed a very low 
copy number of EV-associated HPV genomes or that still other 
I-IPV types are present in these samples, which cannot efficiently be 
detected by our nested PCR. Another hypothesis is tha t HPV is 
o nly in1po rta nt for the initiation but not for the maintenance of the 
malignant phenotype ("hit-and-run" m echmusm). In accordance 
with tlus Jut-and-run hypothesis, Purdie et a/ [20] descr-ibed that 
HPV DNA hybridizing with HPV 5/8 was detectable in two of 
three cell lines derived from skin cancers of renal transplant 
recipients, but o nly at early passages. 
At this moment we can only specula te about the site of active 
virus replication . N either in the study of Purdie el a/ [20] nor in our 
study was it possible to distinguish between HPV DNA contained 
witlun the malignant cells and HPV DNA derived from cells from 
the marginal (e.g., premalignant) tissue. A11 approach developed by 
o ur research group, analyzing al te rnating sections of paraffin-
embedded tissue by m eans of histology and PCR [21), could solve 
tins problem. T herefore, we are currently adapting our PCR 
technique for use on paraffin-embedded tissue. 
Many additional questions rem ain to be solved before it is 
possible to estimate the significance of the apparent presence of 
EV-associated HPV DNA in biopsies of malignant and premalig-
nant skin lesions in relation to tbe pathogenesis of skin cancer, such 
as w hether these EV-associated HPV types are transcriptionally 
active in (pre)malignant skin les ions and, if so, which viral genes are 
transcribed. 
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